|
IAC Express 2007 |
| Issue number 656: April 9, 2007 |
| |
Contents
of this Issue
Select a title to jump to the article. |
- CDC
publishes recommendations for animal rabies prevention and control
- CDC
updates its HPV brochure for clinicians and posts counseling messages on
its HPV web section
- Updated:
IAC revises its professional-education piece on vaccine contraindications
and precautions in adults
- 150
immunization coalitions have posted information on IAC's izcoalitions.org
website—is yours one of them?
-
Immunization Coalitions Technical Assistance Network plans webcast for
April 10 and conference call for April 24
- CDC
reports on measles elimination in South Korea
- CDC adds
novel influenza A virus infections to its National Notifiable Diseases
Surveillance System
- NIAID
plans to expand its programs for influenza research and surveillance
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 656: April 9, 2007 |
|
|
|
1. |
CDC publishes recommendations for animal rabies prevention and control
CDC published "Compendium of Animal Rabies
Prevention and Control, 2007: National Association of State Public Health
Veterinarians, Inc. (NASPHV)" in the April 6 issue of MMWR Recommendations
and Reports. The introductory paragraphs are reprinted below.
Rabies is a fatal viral zoonosis and a serious public health
problem. The disease is an acute progressive encephalitis caused
by a lyssavirus. Multiple viral variants are maintained in wild
mammal populations in the United States, but all mammals are
believed to be susceptible to the disease. For purposes of this
document, use of the term "animal" refers to mammals.
The recommendations in this compendium serve as a basis for
animal rabies-prevention and -control programs throughout the
United States and facilitate standardization of procedures among
jurisdictions, thereby contributing to an effective national
rabies-control program. This document is reviewed annually and
revised as necessary. These recommendations do not supersede
state and local laws or requirements. Principles of rabies
prevention and control are detailed in Part I; recommendations
for parenteral vaccination procedures are presented in Part II,
and all animal rabies vaccines licensed by the U.S. Department
of Agriculture (USDA) and marketed in the United States are
listed in Part III.
To obtain a web-text (HTML) version of the recommendations
online, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5603a1.htm
To obtain a ready-to-copy (PDF) version, go to:
http://www.cdc.gov/mmwr/PDF/rr/rr5603.pdf
Back to top |
| |
|
|
2. |
CDC updates its HPV brochure for clinicians and posts counseling messages on
its HPV web section
CDC recently announced that it has updated the
brochure "Human
Papillomavirus: HPV information for clinicians" and posted four
sets of counseling messages to assist providers in their HPV-related discussions with patients. The counseling messages
address (1) information for parents about the HPV vaccine, (2)
information for women about the Pap and HPV tests, (3)
information for women who receive a positive HPV test result,
and (4) information for patients receiving a genital warts
diagnosis.
To access the brochure and the four counseling messages, go to:
http://www.cdc.gov/std/hpv/hpv-clinicians-brochure.htm and
click on the appropriate link.
In the future, CDC will print the brochure with counseling
insert cards and make it available for free online ordering. IAC
Express will tell readers when the print version is available.
Back to top |
| |
|
|
3. |
Updated: IAC revises its professional-education piece on vaccine
contraindications and precautions in adults
IAC recently updated its one-page
professional-education piece
"Guide to Contraindications and Precautions to Commonly Used
Vaccines in Adults." It now has information on the following
vaccines: Tdap, MMR, HPV, and zoster.
To access a ready-to-print (PDF) version of the revised piece,
go to: http://www.immunize.org/catg.d/p3072.pdf
Back to top |
| |
|
|
4. |
150 immunization coalitions have posted information on IAC's izcoalitions.org
website—is yours one of them?
Since launching its izcoalitions.org website
(http://www.izcoalitions.org) in 2002, IAC has posted
information from 150 immunization coalitions. The site includes
data from coalitions at all levels (local, state, regional, and
national) and of all types, vaccine-specific as well as age-specific (childhood, adult, senior).
This online database allows health professionals, immunization
advocates, parents, and others to contact specific coalitions to
find resources, share ideas, and form strategic partnerships.
Searches can be done by coalition name or geographic area.
Be sure your coalition is part of this powerful web-based
networking tool by logging on and checking for your coalition's
listing. If your coalition is not listed, sign up today. If
you're already signed up, and information about your coalition
has changed, be sure to update your listing to help us keep
izcoalitions.org current and accurate.
To search the izcoalitions.org website, go to:
http://www.izcoalitions.org
If you have questions or difficulties using the website, send an
email to Janelle at janelle@immunize.org or call her at (651)
647-9009.
Back to top |
| |
|
|
5. |
Immunization Coalitions Technical Assistance Network plans webcast for April
10 and conference call for April 24
The Immunization Coalitions Technical Assistance
Network (IZTA)
has scheduled a webcast on evaluating coalitions for April 10
and a conference call on working with the faith-based community
on April 24. The network is a program of the Center for Health
Communication, Academy for Educational Development. Information
on each April program follows.
April 10. A webcast titled "Coalition Evaluation Made Easy"
will be held at 1:00PM, ET, April 10. The presenters are Fran
Butterfoss, PhD, professor and director, Division of Behavioral
Research and Community Health, Department of Pediatrics, Eastern
Virginia Medical School, Norfolk, VA; and Amy Paulson, director,
Consortium for Infant and Child Health, Center for Pediatric
Research, Norfolk, VA.
To register, send an email to izta@aed.org Include this
message: "Sign me up for the coalition evaluation webcast."
April 24. A conference call titled "Extending a C.U.R.E. for
Reaching the Faith-Based Community to Build Immunization
Awareness" will be held at 2:00PM ET, April 24. The presenter is
Hilda R. Carroll-Davis, PhD, MTS, director of faith initiatives,
Commissioner's Office, Tennessee Department of Health.
To register, send an email to izta@aed.org Include this
message: "Sign me up for the faith communities call."
For additional information, or to access earlier programs, go
to:
http://www.izta.org/confcall.cfm
Back to top |
| |
|
|
6. |
CDC reports on measles elimination in South Korea
CDC published "Elimination of Measles—South
Korea, 2001-2006" in
the April 6 issue of MMWR. A portion of a summary made available
to the press is reprinted below.
In late 2006, South Korea became the first country in the WHO
Western Pacific Region to declare measles elimination. As
recently as 2000-2001, a large measles epidemic in the country
resulted in 55,000 reported cases and 7 deaths. Several
strategies led to the successful elimination of measles from the
country: (1) A primary school entry requirement for
documentation of a second dose of measles vaccine was
implemented in 2001, resulting in up to 99 percent coverage
among 7-year-olds. (2) Implementation of a nationwide measles
vaccination campaign among children aged 8-16 in 2001, which
achieved high coverage (97 percent of the target population).
(3) Implementation of case-based measles surveillance and
collection of clinical specimens.
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5613a3.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5613.pdf
To receive a FREE electronic subscription to MMWR (which
includes new ACIP recommendations), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
Back to top |
| |
|
|
7. |
CDC adds novel influenza A virus infections to its National Notifiable
Diseases Surveillance System
CDC published "Notice to Readers: Addition of
Novel Influenza A
Virus Infections to the National Notifiable Diseases
Surveillance System, 2007" in the April 6 issue of MMWR. The
notice is reprinted below in its entirety, excluding references.
On January 9, 2007, the Executive Committee of the Council of
State and Territorial Epidemiologists (CSTE) approved an interim
position statement, adding novel influenza A virus infections to
the National Notifiable Diseases Surveillance System (NNDSS).
This issue of MMWR adds novel influenza A virus infection to
Table I (Provisional cases of infrequently reported notifiable
diseases, United States). The addition of this infection to
NNDSS is expected to facilitate the following: (1) timely
identification and confirmation of cases, (2) timely reporting
of cases to CDC, and (3) early initiation of appropriate health
responses to human infections with novel influenza A viruses
that might have pandemic potential.
These infections must be reported immediately to the World
Health Organization under the revised International Health
Regulations (IHR) approved by the World Health Assembly on May
23, 2005. The revised regulations will take effect in the United
States on June 15, 2007. CDC is collaborating with partners to
develop plans to implement the revised IHR by that date.
To access a web-text (HTML) version of the complete article, go
to: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5613a4.htm
To access a ready-to-print (PDF) version of this issue of MMWR,
go to: http://www.cdc.gov/mmwr/PDF/wk/mm5613.pdf
Back to top |
| |
|
|
8. |
NIAID plans to expand its programs for influenza research and surveillance
On April 2, the National Institutes of Health
announced that the
National Institute of Allergy and Infectious Diseases (NIAID)
plans to expand its capability for influenza research and
surveillance. The announcement's opening paragraph is reprinted
below.
The National Institute of Allergy and Infectious Diseases
(NIAID), part of the National Institutes of Health (NIH), today
announced it is awarding $23 million per year for seven years to
establish six Centers of Excellence for Influenza Research and
Surveillance. Collectively, the centers will expand NIAID's
influenza surveillance program internationally and in the United
States, and will bolster influenza research in key areas,
including understanding how the virus causes disease and how the
human immune system responds to infection with the virus. The
goal of the newly created centers is to provide the federal
government with important information to inform public health
strategies for controlling and lessening the impact of seasonal
influenza as well as an influenza pandemic.
To access the complete announcement, go to:
http://www.nih.gov/news/pr/apr2007/niaid-02.htm
Back to top |
| |
|
|
